Novanta (NASDAQ:NOVT – Get Free Report) updated its fourth quarter 2026 earnings guidance on Tuesday. The company provided earnings per share guidance of 0.910-0.960 for the period, compared to the consensus estimate of 1.020. The company issued revenue guidance of $306.0 million-$312.0 million, compared to the consensus revenue estimate of $308.6 million. Novanta also updated its FY 2026 guidance to 3.660-3.710 EPS.
Analysts Set New Price Targets
Several research firms have commented on NOVT. Wall Street Zen raised shares of Novanta from a “hold” rating to a “buy” rating in a research report on Saturday. Weiss Ratings restated a “hold (c-)” rating on shares of Novanta in a report on Tuesday, October 13th. Robert W. Baird set a $194.00 target price on shares of Novanta in a research report on Friday, August 7th. Finally, Zacks Research downgraded Novanta from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 6th. One investment analyst has rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $194.00.
Check Out Our Latest Stock Report on Novanta
Novanta Trading Down 15.1%
Shares of NOVT opened at $123.94 on Tuesday. The business’s 50-day moving average price is $142.25 and its 200 day moving average price is $142.59. The company has a current ratio of 4.57, a quick ratio of 3.79 and a debt-to-equity ratio of 0.12. The stock has a market capitalization of $4.69 billion, a P/E ratio of 86.50 and a beta of 1.71. Novanta has a 1-year low of $98.27 and a 1-year high of $176.38.
Novanta (NASDAQ:NOVT – Get Free Report) last announced its quarterly earnings data on Monday, November 9th. The technology company reported $1.05 EPS for the quarter, beating analysts’ consensus estimates of $0.97 by $0.08. The firm had revenue of $305.01 million for the quarter, compared to the consensus estimate of $301.02 million. Novanta had a net margin of 6.00% and a return on equity of 10.83%. The firm’s revenue was up 23.1% on a year-over-year basis. During the same period in the previous year, the firm posted $0.87 earnings per share. Analysts expect that Novanta will post 3.70 earnings per share for the current year.
About Novanta
Novanta develops and manufactures precision technologies used in medical and advanced industrial applications. Its products include photonics and laser components, precision motion-control systems, machine-vision technologies, and related equipment and software.
The company’s technologies are used in areas such as medical and surgical systems, life sciences, robotics, and industrial automation. Novanta serves customers internationally, with operations and customers across North America, Europe, and Asia.
Novanta was formerly known as GSI Group and adopted the Novanta name in 2016.
See Also
- Five stocks we like better than Novanta
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.
